Cargando…
Risk of Thromboembolism With Eltrombopag: A Case Report of Deep Vein Thrombosis and Bilateral Pulmonary Embolism
Eltrombopag is a second-line therapy for refractory thrombocytopenia from immune thrombocytopenic purpura (ITP). The medication is generally well tolerated but can lead to adverse thromboembolic complications in rare instances. We present a case of lower extremity deep vein thrombosis with bilateral...
Autores principales: | Ghumman, Ghulam Mujtaba, Fatima, Huda, Singh, Gunbir, Khalid, Taha, Ayoubi, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911261/ https://www.ncbi.nlm.nih.gov/pubmed/36788875 http://dx.doi.org/10.7759/cureus.33615 |
Ejemplares similares
-
Bilateral Popliteal Vein Thrombosis, Acute Pulmonary Embolism and Mild COVID-19
por: Suwanwongse, Kulachanya, et al.
Publicado: (2020) -
Severe Portal Vein Thrombosis During Eltrombopag Treatment Concomitant Splenectomy for Immune Thrombocytopenia
por: Saito, Makoto, et al.
Publicado: (2021) -
Bilateral Renal Vein Thrombosis in Membranous Nephropathy: Hypoalbuminemia Predictive of Venous Thromboembolism in Nephrotic Syndrome
por: Casey, Derek, et al.
Publicado: (2022) -
Pulmonary Tuberculosis With Saddle Pulmonary Embolism and Deep Vein Thrombosis: A Rare Case Report
por: Subahi, Eihab A, et al.
Publicado: (2021) -
Portal Vein Thrombosis in a Patient With Methylenetetrahydrofolate Reductase Gene Mutation and Normal Homocysteine Levels
por: Ghumman, Ghulam Mujtaba, et al.
Publicado: (2021)